Scientists discovered compounds in a Brazilian tree that hit SARS-CoV-2 on a number of fronts, revealing a promising new lead within the seek for COVID-19 remedies.
Researchers have discovered that galloylquinic acids extracted from the leaves of Copaifera lucens Dwyer, a tree native to Brazil and located primarily within the Atlantic Forest, can act towards SARS-CoV-2 in a number of other ways. SARS-CoV-2 is the virus chargeable for COVID-19.
The crew chosen this species as a result of researchers led by Jairo Kenupp Bastos have in depth expertise learning the chemistry and pharmacology of Copaifera crops. Bastos is a pharmacist and professor on the Ribeirão Preto Faculty of Pharmaceutical Sciences on the College of São Paulo (FCFRP-USP) and coordinated the examine.
Plant Compounds With Broad Organic Exercise
Galloylquinic acids have already attracted scientific curiosity due to their wide selection of reported organic results. Earlier analysis has discovered antifungal and anticancer exercise in vitro and in vivo, together with broad-spectrum antiviral properties.
Derivatives of those compounds have additionally proven robust inhibitory results towards HIV-1 in biochemical assessments and cell cultures, whereas displaying decrease toxicity than among the different molecules examined.
For the brand new examine, which was supported by FAPESP, the researchers first ready and characterised fractions from the plant leaves that had been wealthy in galloylquinic acids. They then carried out cytotoxicity assessments to find out how safely the compounds might be launched into host cells.
Testing the Compounds In opposition to SARS-CoV-2
The crew evaluated antiviral exercise utilizing plaque discount assays, which measure how successfully antibodies or antiviral compounds can neutralize a virus. The assessments confirmed robust exercise towards SARS-CoV-2.
The researchers additionally examined viral protein manufacturing and the best way the compounds interacted with a number of necessary viral targets. These included the receptor-binding area of the spike protein, which helps SARS-CoV-2 enter human cells, papain-like protease (PLpro), an enzyme concerned in serving to the virus evade host defenses, and RNA polymerase, an enzyme the virus wants to repeat its genetic materials and reproduce.
“This built-in strategy allowed us to grasp how the compounds work and the way they act on the molecular stage,” mentioned Mohamed Abdelsalam, an assistant professor of pharmacognosy and pure product chemistry on the College of Pharmacy on the Delta College of Science and Know-how in Egypt.
A Multi-Goal Assault on the Virus
The findings, revealed within the journal Scientific Reviews, confirmed that galloylquinic acids had robust exercise towards the coronavirus variant examined. The compounds interfered with viral entry into cells, viral replication, and the manufacturing of viral proteins.
The substances even have anti-inflammatory and immunomodulatory properties, which means they could affect how the immune system responds throughout an infection. That impact might be particularly related in extreme circumstances of COVID-19, when an excessively aggressive immune response can contribute to problems.
“An necessary side revealed by this data is the multi-target mechanism of the compound, which reduces the probability of resistance creating. It is because many present antivirals act on just one viral protein, which promotes this impact,” says Bastos.
Extra Testing Is Nonetheless Wanted
The findings are promising, however the compounds usually are not but able to be developed right into a COVID-19 remedy. Extra work shall be required, together with in vivo research and medical trials, earlier than researchers can decide whether or not they may change into protected and efficient medicines.
Even so, the outcomes spotlight the potential worth of biodiversity and natural-product analysis within the seek for new therapeutic candidates. Additionally they reinforce the concept Brazil’s wealthy plants may function an necessary supply of molecules for future drug growth.
Reference: “Bioactive galloylquinic acids from Copaifera lucens as twin inhibitors of SARS-CoV-2 Spike and RdRp proteins” by Rasha M. El-Morsi, Lamiaa A. Al-Madboly, Jairo Ok. Bastos, Shaimaa M. Aboukhatwa, Samah A. Nasr, Doaa A. Ghareeb, Heba A. Ramadan, Ivan Kushkevych and Mohamed A. Abd El-Salam, 2 February 2026, Scientific Reviews.
DOI: 10.1038/s41598-025-25217-8
